Although several studies have explored factors associated with loss to follow-up (LTFU) from HIV care, there remains a gap in understanding how these factors vary by setting, volume of patient and patients’ demographic and clinical characteristics. We determined rates and factors associated with LTFU in HIV care Lilongwe, Malawi
Introduction: African studies have reported high rates of loss to follow up (LTFU) among childr...
Background Poor rates of linkage from HIV diagnosis to ART initiation are a major barrier to univ...
OBJECTIVE: The vital status of patients lost to follow-up often remains unknown in antiretroviral th...
IntroductionAlthough several studies have explored factors associated with loss to follow-up (LTFU) ...
OBJECTIVE: To determine the rate and predictors of early loss to follow-up (LTFU) for recently diagn...
Lifelong antiretroviral therapy (ART) improves health outcomes for HIV-positive individuals, but is ...
OBJECTIVE: To determine the loss to follow-up (LTFU) rates at different healthcare levels after anti...
Abstract Background Loss to follow-up is a major challenge of antiretroviral treatment (ART) program...
BACKGROUND:Retaining patients starting antiretroviral therapy (ART) and ensuring good adherence rema...
Losses to Follow-Up from Antiretroviral Therapy (ART) programs remain a challenge in Malawi. The ob...
Losses to follow-up (LTFU) remain an important programmatic challenge. While numerous patient-level ...
INTRODUCTION: Over time, there has been a substantial improvement in antiretroviral treatment (ART) ...
Antiretroviral therapy (ART) improves morbidity and mortality in patients with HIV, however high rat...
BACKGROUND: Many HIV treatment programs in resource-limited settings are plagued by high rates of lo...
Background: Lost to follow-up (LTFU) is a major challenge that hinders the success of antiretroviral...
Introduction: African studies have reported high rates of loss to follow up (LTFU) among childr...
Background Poor rates of linkage from HIV diagnosis to ART initiation are a major barrier to univ...
OBJECTIVE: The vital status of patients lost to follow-up often remains unknown in antiretroviral th...
IntroductionAlthough several studies have explored factors associated with loss to follow-up (LTFU) ...
OBJECTIVE: To determine the rate and predictors of early loss to follow-up (LTFU) for recently diagn...
Lifelong antiretroviral therapy (ART) improves health outcomes for HIV-positive individuals, but is ...
OBJECTIVE: To determine the loss to follow-up (LTFU) rates at different healthcare levels after anti...
Abstract Background Loss to follow-up is a major challenge of antiretroviral treatment (ART) program...
BACKGROUND:Retaining patients starting antiretroviral therapy (ART) and ensuring good adherence rema...
Losses to Follow-Up from Antiretroviral Therapy (ART) programs remain a challenge in Malawi. The ob...
Losses to follow-up (LTFU) remain an important programmatic challenge. While numerous patient-level ...
INTRODUCTION: Over time, there has been a substantial improvement in antiretroviral treatment (ART) ...
Antiretroviral therapy (ART) improves morbidity and mortality in patients with HIV, however high rat...
BACKGROUND: Many HIV treatment programs in resource-limited settings are plagued by high rates of lo...
Background: Lost to follow-up (LTFU) is a major challenge that hinders the success of antiretroviral...
Introduction: African studies have reported high rates of loss to follow up (LTFU) among childr...
Background Poor rates of linkage from HIV diagnosis to ART initiation are a major barrier to univ...
OBJECTIVE: The vital status of patients lost to follow-up often remains unknown in antiretroviral th...